Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 5:42 AM GMTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...